These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35112886)

  • 41. Evaluation of the electrocardiographic criteria for left ventricular hypertrophy.
    Morrison I; Clark E; Macfarlane PW
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():159-63. PubMed ID: 17584713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients.
    Kim SJ; Oh HJ; Yoo DE; Shin DH; Lee MJ; Kim HR; Park JT; Han SH; Yoo TH; Choi KH; Kang SW
    PLoS One; 2012; 7(4):e35534. PubMed ID: 22530043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrocardiographic criteria for left ventricular hypertrophy in aortic valve stenosis: Correlation with echocardiographic parameters.
    Bula K; Ćmiel A; Sejud M; Sobczyk K; Ryszkiewicz S; Szydło K; Wita M; Mizia-Stec K
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12645. PubMed ID: 30896064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
    Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
    Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
    Dobner S; Pilgrim T; Hagemeyer D; Heg D; Lanz J; Reusser N; Gräni C; Afshar-Oromieh A; Rominger A; Langhammer B; Reineke D; Windecker S; Stortecky S
    J Am Heart Assoc; 2023 Aug; 12(16):e030271. PubMed ID: 37581394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data).
    Greve AM; Gerdts E; Boman K; Gohlke-Baerwolf C; Rossebø AB; Hammer-Hansen S; Køber L; Willenheimer R; Wachtell K
    Am J Cardiol; 2011 Aug; 108(4):541-7. PubMed ID: 21624542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
    Pedersen ALD; Povlsen JA; Rasmussen VG; Frederiksen CA; Christiansen EH; Terkelsen CJ; Vase H; Poulsen SH
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):13-22. PubMed ID: 36598683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
    Oh JK; Lee SH; Lee SA; Kang DY; Lee S; Kim HJ; Ahn JM; Kim JB; Park DW; Song JM; Choo SJ; Kang DH; Song JK; Park SJ; Kim DH
    Int J Cardiol; 2021 Jun; 332():60-66. PubMed ID: 33781852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy in Severe Aortic Stenosis.
    Budkiewicz A; Surdacki MA; Gamrat A; Trojanowicz K; Surdacki A; Chyrchel B
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34072214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Relevance of Left Ventricular Myocardial Performance After Transcatheter Aortic Valve Replacement.
    Asami M; Pilgrim T; Lanz J; Heg D; Franzone A; Piccolo R; Langhammer B; Praz F; Räber L; Valgimigli M; Roost E; Windecker S; Stortecky S
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e006612. PubMed ID: 30626203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.
    Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C
    Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement.
    Angeli F; Verdecchia P; Angeli E; Poeta F; Sardone M; Bentivoglio M; Prosciutti L; Cocchieri M; Zollino L; Bellomo G; Rondoni F; Garognoli O; Lenti S; Frigerio C; Gattobigio R; Benemio G; Biscottini B; Panciarola R; Buccolieri M; Liberati R; Trottini M; Cipollini F; Gemelli F; Schillaci G; Porcellati C
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):812-6. PubMed ID: 17060807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Rozenbaum Z; Finkelstein A; Zhitomirsky S; Topilsky Y; Halkin A; Banai S; Bazan S; Barbash I; Segev A; Guetta V; Danenberg H; Planner D; Orvin K; Assa HV; Assali A; Kornowski R; Steinvil A
    Am Heart J; 2020 Feb; 220():184-191. PubMed ID: 31862472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.
    Pedersen LR; Kristensen AMD; Petersen SS; Vaduganathan M; Bhatt DL; Juel J; Byrne C; Leósdóttir M; Olsen MH; Pareek M
    J Clin Hypertens (Greenwich); 2020 Sep; 22(9):1647-1658. PubMed ID: 32813895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta-analysis of electrocardiographic studies.
    Zhang H; Hu L; Wei X
    J Clin Hypertens (Greenwich); 2020 Feb; 22(2):254-260. PubMed ID: 31955500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality.
    Afify HMA; Waits GS; Ghoneum AD; Cao X; Li Y; Soliman EZ
    Front Cardiovasc Med; 2018; 5():75. PubMed ID: 30013976
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of obesity on electrocardiographic detection of hypertensive left ventricular hypertrophy: recalibration against cardiac magnetic resonance.
    Rodrigues JC; McIntyre B; Dastidar AG; Lyen SM; Ratcliffe LE; Burchell AE; Hart EC; Bucciarelli-Ducci C; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    J Hum Hypertens; 2016 Mar; 30(3):197-203. PubMed ID: 26040440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.